Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.

Alexis WerionPauline StormsYsaline ZiziClaire BeguinJelle BernardsJean-François CambierKarin DahanDaan DierickxNathalie GodefroidPascale HilbertCatherine LambertElena LevtchenkoThomas MeyskensXavier PoiréLambert Van den HeuvelKathleen J ClaesJohann Morellenull null

Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)

Secondary TMA represent the main cause of TMA and are independently associated with a high risk of death and progression to kidney failure.

Keyphrases

copy number
genome wide
risk factors